In its final Medicare Physician Fee Schedule rule released on November 1, 2018, CMS outlined future plans to implement material changes as to how new and established office visits (i.e., evaluation and management [E&M] codes) will be reimbursed.
As we look forward to 2019, the hospital/health system M&A market is increasingly becoming a bifurcated landscape of clear “haves” and “have-nots”.
ECG is a proud sponsor and exhibitor at the ACCC 45th Annual Meeting & Cancer Center Business Summit in Washington, DC.
ECG’s 2018 Physician Compensation Survey provides market-specific data. This year’s data showed that the major issues motivating organizations to examine and reconfigure compensation arrangements are financial performance, migration to value based reimbursement systems, and pressures from nontraditional competitors.
We recently sat down with Dr. Cullen to hear more about his transition from primary care practice to consulting as well as his views on the challenges facing the healthcare industry today.
To be successful under value-based payment, a health system requires collaborative and binding relationships with affiliated physicians; the professional service agreements the organizations enters with the physicians should be designed to firmly establish such relationships.
On December 27, 2018, the United States District Court for the District of Columbia granted a permanent injunction on the 2018 Medicare reimbursement cuts related to 340B drugs. What does this mean for the hospitals affected by these changes?
In November, healthcare information technology companies hit end-of-year numbers rivaling those of the long-term care, physician practice, and health and hospital system sectors.
As the year comes to an end, ECG interviewed CEOs and other C-suite leaders at more than 100 healthcare provider organizations to explore the greatest “stay awake” issues facing hospitals and physicians.
Page 1 of 280